ECG
LHDX

EPIQ Capital Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

EPIQ Capital Group’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-725,675
Closed -$80.5K – 55
2022
Q4 		$80.5K Sell
725,675
-13,011,695
-95% -$8.3M 0.04% 47
2022
Q3 		$14.6M Buy
13,737,370
+97,502
+0.7% +$222K 7.17% 6
2022
Q2 		$25.4M Sell
13,639,868
-293,752
-2% -$714K 9.96% 4
2022
Q1 		$49.7M Sell
13,933,620
-62,630
-0.4% -$308K 13.6% 2
2021
Q4 		$121M Buy
13,996,250
+200,067
+1% +$1.27M 21.41% 2
2021
Q3 		$105M Buy
13,796,183
+502,733
+4% +$4.24M 10.84% 3
2021
Q2 		$88.3M Buy
13,293,450
+59,865
+0.5% +$377K 9.22% 3
2021
Q1 		$160M Buy
+13,233,585
New +$262M 17.88% 2

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $2.57B AUM
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

EPIQ Capital Group's LHDX Position: Q1 2023 in Review

EPIQ Capital Group sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 725,675 shares — an estimated $80.5K sold.

EPIQ Capital Group first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $160M in Q1 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • EPIQ Capital Group reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • EPIQ Capital Group sold 725,675 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $80.5K.
  • EPIQ Capital Group first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • EPIQ Capital Group's Lucira Health, Inc. Common Stock position peaked at $160M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on EPIQ Capital Group's 13F filing for Q1 2023, filed 11 May 2023.